“Covalon has supported the efforts of the SAWC for years and we are proud to do so,” said Brian Pedlar, Chief Executive Officer of Covalon. “Our position as an emerging leader in the advanced wound care space makes this an important springboard for the following year of activity” Pedlar continued.

SAWC Fall serves as a forum to connect the entire wound care team — physicians, nurses, physical therapists, researchers, scientists, podiatrists, and dietitians — with the foremost experts in wound care to improve patient outcomes through education. No other wound care conference offers the level of education, advanced state-of-the-art clinical reviews and emerging research findings.

In addition to exhibiting, Covalon’s ColActive® Transfer will be featured in a case study entitled: Assessment of a Novel Biomatrix Wound Contact Layer in Conjunction with NPWT on an Abdominal Surgical Wound, which demonstrates its unique ability to work under Negative Pressure Wound Therapy conditions.

Covalon offers unique, patent protected infection management and advanced wound management solutions for the wound clinician. Covalon’s CovaWound™ and ColActive® brands when used together have the ability to rapidly promote wound closure and healing in both acute and chronic wounds.

Visit the Covalon Technologies Ltd. booth #138 from October 7-9th at the Caesar’s Palace Convention Center in Las Vegas.

Covalon Technologies researches, develops and commercializes new healthcare technologies that help save lives around the world. Covalon's patented technologies, products and services address the advanced healthcare needs of medical device companies, healthcare providers and individual consumers.